Literature DB >> 2439641

Fine mapping of epitopes by intradomain Kd/Dd recombinants.

J P Abastado, C Jaulin, M P Schutze, P Langlade-Demoyen, F Plata, K Ozato, P Kourilsky.   

Abstract

11 intradomain recombinants between H-2Kd and H-2Dd were produced using an original technique based on in vivo recombination in Escherichia coli. After transfection into mouse L cells, all these recombinants were expressed at high levels on the cell surface. The specificities of 77 mAbs were examined on these cell lines. mAbs could be organized in 12 groups. In each group, a small number of amino acids participating in the recognized epitope(s) were identified. In a few instances, noncontinuous epitopes comprising amino acids belonging to different domains of the antigen were found. The data thus obtained are compatible with those produced in previous exon-shuffling experiments, but permit a much more precise definition of recognized epitope(s).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439641      PMCID: PMC2189604          DOI: 10.1084/jem.166.2.327

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Studies on monoclonal antibodies to mouse MHC products.

Authors:  K Ozato; S L Epstein; P Henkart; T H Hansen; D H Sachs
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

2.  Monoclonal antibodies specific for class I and class II molecules controlled by the mouse H-2 complex.

Authors:  S Tewarson; F Figueroa; J Klein
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens.

Authors:  G A Evans; D H Margulies; B Shykind; J G Seidman; K Ozato
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

4.  Ten new monoclonal antibodies detecting antigenic determinants on class I H-2 molecules.

Authors:  F Figueroa; W C Davis; J Klein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Recognition of conformational determinants on H-2 by cytolytic T lymphocytes.

Authors:  L A Sherman
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

6.  A cDNA clone containing the entire coding sequence of a mouse H-2Kd histocompatibility antigen.

Authors:  J L Lalanne; C Delarbre; G Gachelin; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  DNA sequence of a gene encoding a BALB/c mouse Ld transplantation antigen.

Authors:  K W Moore; B T Sher; Y H Sun; K A Eakle; L Hood
Journal:  Science       Date:  1982-02-05       Impact factor: 47.728

8.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

9.  Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12.

Authors:  F Colbere-Garapin; S Chousterman; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

10.  New family of exon-shuffled recombinant genes reveals extensive interdomain interactions in class I histocompatibility antigens and identifies residues involved.

Authors:  M J Darsley; H Takahashi; M J Macchi; J A Frelinger; K Ozato; E Appella
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  12 in total

1.  Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.

Authors:  Yohko Nakagawa; Hiroto Kikuchi; Hidemi Takahashi
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

2.  Single Dd amino acid substitutions in the H-2Ld molecule identify antibody epitopes.

Authors:  D M McKinney; P Chen; M McMillan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.

Authors:  H G Rammensee; H Schild; U Theopold
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.

Authors:  M Orihuela; D H Margulies; W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.

Authors:  M Shirai; T Akatsuka; C D Pendleton; R Houghten; C Wychowski; K Mihalik; S Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.

Authors:  M Shirai; H Okada; M Nishioka; T Akatsuka; C Wychowski; R Houghten; C D Pendleton; S M Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.

Authors:  D Koeller; R Lieberman; J Miyazaki; E Appella; K Ozato; D W Mann; J Forman
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

8.  Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness.

Authors:  J P Abastado; Y C Lone; A Casrouge; G Boulot; P Kourilsky
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

9.  Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.

Authors:  E Mottez; P Langlade-Demoyen; H Gournier; F Martinon; J Maryanski; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d).

Authors:  M C Nakamura; S Hayashi; E C Niemi; J C Ryan; W E Seaman
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.